X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (542) 542
Publication (42) 42
Book Review (6) 6
Newsletter (5) 5
Book Chapter (3) 3
Conference Proceeding (3) 3
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
exenatide (426) 426
index medicus (374) 374
animals (297) 297
humans (251) 251
male (220) 220
glucagon-like peptide-1 (198) 198
type 2 diabetes (167) 167
glucose (160) 160
diabetes (158) 158
diabetes mellitus, type 2 - drug therapy (149) 149
peptides (148) 148
pharmacology & pharmacy (146) 146
exendin-4 (139) 139
rats (132) 132
insulin (128) 128
endocrinology & metabolism (126) 126
peptides - pharmacology (126) 126
mice (124) 124
glucagon (116) 116
biochemistry & molecular biology (111) 111
venoms - pharmacology (105) 105
female (104) 104
glp-1 (95) 95
liraglutide (91) 91
glucagon-like peptide-1 receptor (89) 89
glycemic control (89) 89
hypoglycemic agents - pharmacology (86) 86
hypoglycemic agents - therapeutic use (86) 86
hypoglycemic agents - administration & dosage (81) 81
peptides - chemistry (80) 80
insulin - metabolism (79) 79
peptides - administration & dosage (77) 77
hypoglycemic agents (75) 75
analysis (74) 74
middle aged (74) 74
diabetes mellitus (71) 71
venoms - chemistry (69) 69
venoms - administration & dosage (66) 66
peptides - therapeutic use (65) 65
blood glucose - metabolism (64) 64
insulin secretion (63) 63
glucagon-like peptide 1 (59) 59
blood glucose - drug effects (58) 58
rats, sprague-dawley (58) 58
dextrose (57) 57
hypoglycemic agents - pharmacokinetics (56) 56
mice, inbred c57bl (55) 55
receptor (55) 55
pharmacokinetics (54) 54
adult (53) 53
peptides - pharmacokinetics (52) 52
receptors, glucagon - agonists (52) 52
research (52) 52
venoms - therapeutic use (52) 52
amino acid sequence (51) 51
glucagon-like peptide 1 - analogs & derivatives (51) 51
diabetes mellitus, type 2 - blood (50) 50
hypoglycemic agents - chemistry (50) 50
metformin (49) 49
venoms - pharmacokinetics (49) 49
chemistry, multidisciplinary (47) 47
obesity (47) 47
cell line (46) 46
open-label (45) 45
receptors, glucagon - metabolism (45) 45
expression (43) 43
insulin resistance (43) 43
molecular sequence data (43) 43
diabetes mellitus, type 2 - metabolism (42) 42
exenatide exendin-4 (42) 42
physiology (42) 42
rodents (42) 42
aged (41) 41
diabetes therapy (41) 41
physiological aspects (41) 41
health aspects (40) 40
beta-cell function (39) 39
glucagon-like peptide-1 receptor - agonists (39) 39
hypoglycemic agents - adverse effects (39) 39
pancreas (39) 39
secretion (39) 39
care and treatment (38) 38
proteins (38) 38
chemistry, medicinal (37) 37
drugs (37) 37
insulin-secreting cells - metabolism (37) 37
insulin-secretion (37) 37
metabolism (37) 37
treated patients (37) 37
in-vitro (35) 35
medicine (35) 35
blood sugar (34) 34
body weight (34) 34
glucagon-like peptide-1 receptor - metabolism (34) 34
apoptosis (33) 33
dose-response relationship, drug (33) 33
glucagon-like peptide 1 - metabolism (33) 33
treatment outcome (33) 33
type-2 diabetes-mellitus (33) 33
endocrine system (32) 32
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biomaterials, ISSN 0142-9612, 2013, Volume 34, Issue 11, pp. 2834 - 2842
Journal Article
Amino Acids, ISSN 0939-4451, 4/2016, Volume 48, Issue 4, pp. 1059 - 1067
Common yet often overlooked, deamidation of peptidyl asparagine (Asn or N) generates aspartic acid (Asp or D) or isoaspartic acid (isoAsp or isoD). Being a... 
Biochemistry, general | Isoaspartic acid | Isomerization | Neurobiology | Deamidation | Exenatide | Artifact | Life Sciences | Analytical Chemistry | Adrenocorticotropic hormone | Life Sciences, general | Biochemical Engineering | Proteomics | Mass spectrometry | Glu-C | Calmodulin | PROTEIN ISOASPARTATE METHYLTRANSFERASE | SAMPLE PREPARATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | RECOMBINANT MONOCLONAL-ANTIBODY | ELECTRON-TRANSFER DISSOCIATION | CHEMICAL PATHWAYS | TISSUE-PLASMINOGEN-ACTIVATOR | LIQUID-CHROMATOGRAPHY | PEPTIDE DEGRADATION | MASS-SPECTROMETRY ANALYSIS | ASPARAGINE RESIDUES | Amino Acid Sequence | Peptides - chemistry | Adrenocorticotropic Hormone - chemistry | Serine Endopeptidases - chemistry | Artifacts | Animals | Isoaspartic Acid - chemistry | Solutions | Cattle | Proteolysis | Amides - chemistry | Protein Processing, Post-Translational | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Aspartic Acid - chemistry | Venoms - chemistry | Buffers | Calmodulin - chemistry | Asparagine - chemistry | Hydrogen-Ion Concentration | Post-translational modification | Peptides | ACTH | Aspartate | Proteases | Analysis | Asparagine | Carbonates | Hydrogen-ion concentration | Proteins | Bicarbonates | Amino acids | Aspartic acid | Digestion | deamidation | artifact | isomerization | mass spectrometry | calmodulin | isoaspartic acid | adrenocorticotropic hormone | exenatide
Journal Article
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, p. e0145838
Background The two major obstacles in the successful transplantation of islets for diabetes treatment are inadequate supply of insulin-producing tissue and... 
PATHWAYS | MANIPULATION | RAT | MECHANISM | MULTIDISCIPLINARY SCIENCES | PANCREATIC BETA-CELLS | GENERATION | TRANSPLANTATION | Chondrocytes - cytology | Calcium Channels - metabolism | Streptozocin | Humans | Adipocytes - cytology | Male | Transplantation, Heterologous | Dithizone - chemistry | Exenatide | Diabetes Mellitus, Experimental - therapy | Niacinamide - chemistry | Karyotyping | Mesenchymal Stem Cells - cytology | Cell Differentiation | Insulin-Secreting Cells - cytology | Culture Media - chemistry | Diabetes Mellitus, Experimental - metabolism | Peptides - chemistry | Bone Marrow Cells - cytology | Hyperglycemia - metabolism | Insulin - metabolism | Phenotype | Animals | Mice, Nude | Glucose - chemistry | Mice | Mice, Inbred BALB C | Venoms - chemistry | Hyperglycemia - therapy | Mesenchymal Stem Cell Transplantation | Osteogenesis | Apoptosis | Complications and side effects | Hyperglycemia | Care and treatment | Patient outcomes | Stem cells | Transplantation | NADPH | Immunohistochemistry | Pediatrics | Transplants & implants | Mesenchyme | Laboratories | Syngeneic grafts | Staining | Stimulation | Glucose | Bone surgery | Allografts | Education | Rodents | Bone marrow | Autografts | Calcium (intracellular) | Channel gating | Diabetes mellitus | Pancreatic islet transplantation | Gene expression | Insulin | Graft rejection | Hospitals | Calcium channels (L-type) | Islet cells | Pancreas transplantation | Nicotinamide | Diabetes | Umbilical cord | Differentiation | Immunofluorescence | Human behavior | Endocrinology | Kidney transplantation
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 3/2015, Volume 32, Issue 3, pp. 1017 - 1027
Exenatide, a potent insulinotropic agent, can be used for the treatment of non-insulin-dependent diabetes mellitus. However, the need for frequent injections... 
Biochemistry, general | Biomedical Engineering | goblet cell-targeting nanoparticles | Biomedicine | Pharmacy | in vivo image system | Medical Law | CSK peptide-modified chitosan | oral delivery system | Pharmacology/Toxicology | exenatide | DB/DB MICE | CHITOSAN | RECEPTOR | PHARMACODYNAMICS | CHEMISTRY, MULTIDISCIPLINARY | TRANSPORT | PHARMACOKINETICS | EXENDIN-4 | DRUGS | PHARMACOLOGY & PHARMACY | MUCUS | AGONIST | Humans | Peptides - pharmacokinetics | Male | Intestinal Absorption | Peptides - administration & dosage | Drug Carriers | Nanoparticles | Tissue Distribution | Hypoglycemic Agents - administration & dosage | Biotransformation | Venoms - administration & dosage | Nanomedicine | Oligopeptides - chemistry | Caco-2 Cells | Cell Survival - drug effects | Hypoglycemic Agents - pharmacokinetics | Peptides - chemistry | Administration, Oral | Technology, Pharmaceutical - methods | Hypoglycemic Agents - chemistry | Oligopeptides - metabolism | Oligopeptides - toxicity | Permeability | Goblet Cells - metabolism | Rats, Sprague-Dawley | Chemistry, Pharmaceutical | Blood Glucose - drug effects | HT29 Cells | Animals | Chitosan - chemistry | Venoms - chemistry | Blood Glucose - metabolism | Venoms - pharmacokinetics | Type 2 diabetes | Peptides | Therapeutics | Fluorescence | Hypoglycemic agents | Glucose | Dextrose | Homeopathy | Materia medica and therapeutics | Drug delivery systems | Diabetes | Pharmaceutical sciences | Index Medicus
Journal Article
Molecules, ISSN 1420-3049, 02/2019, Volume 24, Issue 4, p. 779
Glucagon-like peptide-1 receptor (GLP-1R) agonists have emerged as treatment options for type 2 diabetes mellitus (T2DM). Here, we designed a high-throughput... 
Antidiabetic effects | Extracellular domain | Fatty chain | Exendin-4 | Glucagon-like peptide-1 receptor | fatty chain | extracellular domain | CRYSTAL-STRUCTURE | BIOCHEMISTRY & MOLECULAR BIOLOGY | PROTEIN-COUPLED RECEPTORS | INHIBITORS | CHEMISTRY, MULTIDISCIPLINARY | antidiabetic effects | GLUCAGON | Glycoconjugates - metabolism | Glycoconjugates - chemistry | Obesity - drug therapy | Hypoglycemic Agents - metabolism | Glycoconjugates - pharmacology | Diet, High-Fat - adverse effects | Male | Structure-Activity Relationship | Peptide Library | Hyperglycemia - drug therapy | Obesity - genetics | Hyperglycemia - genetics | Glucagon-Like Peptide-1 Receptor - genetics | Glucagon-Like Peptide-1 Receptor - metabolism | Insulin-Secreting Cells - metabolism | Peptides - metabolism | Obesity - etiology | Binding Sites | Exenatide - genetics | Amino Acid Sequence | Cell Line | Glucose Tolerance Test | Fatty Acids - chemistry | Peptides - chemistry | Gene Expression Regulation | Rats | Hypoglycemic Agents - chemistry | Hypoglycemic Agents - pharmacology | Obesity - metabolism | Peptides - pharmacology | Hyperglycemia - metabolism | Animals | Insulin-Secreting Cells - drug effects | Protein Binding | Hyperglycemia - etiology | Mice | Insulin-Secreting Cells - pathology | Exenatide - metabolism | Glucagon-Like Peptide-1 Receptor - agonists | Conjugates | Peptides | Diabetes mellitus | Amino acids | Bioavailability | Glucose | Metabolism | Reduction | Weight control | Mutagenesis | Insulin resistance | Ligands | Libraries | Acylation
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 08/2013, Volume 8, Issue 1, pp. 2975 - 2983
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 06/2017, Volume 12, pp. 4663 - 4678
Journal Article